20-F: Kelso returns to profit, targets 2026 AAR approval

Kelso Technologies posted a 2025 profit on flat revenue, tightened costs, and advanced its K2AV angle valve toward expected AAR approval in 2026 amid tariff headwinds and internal control weaknesses.

Summary

• Reported revenue of $10,784,090 (+1% YoY) and net income of $447,397 (vs. 2024 net loss of $4,622,297); Adjusted EBITDA of $347,723 (vs. 2024 loss of $1,249,326).
• Gross profit was $4,432,744 with a 41% margin (down from 44% in 2024) due to sales mix and inclusion of $40,232 inventory write-offs in COGS.
• Operating expenses fell to $3,989,053 (from $5,527,559), driven by lower consulting, legal, and admin costs; cost controls intensified in 2025.
• Working capital improved to $2,541,625 (2024: $2,125,387); cash was $399,375; inventory $2,206,770; accounts receivable $632,568.
• Total assets were $5,469,476; shareholders’ equity was $4,676,425 at December 31, 2025.
• Line of credit increased to $1,000,000 (undrawn at year-end), at WSJ Prime + 1.00% (Prime 6.75% at 12/31/25).
• K2AV angle valve field service trial largely completed in 2025 with no major customer issues reported; AAR approval anticipated in 2026.
• Completion of the pressure car kit could lift revenue per pressure car from ~$1,500 to over $10,000 once K2AV gains approval.
• KXI automotive suspension R&D was discontinued in 2024; assets/prototypes impaired to $1; exploring sale/licensing/royalty options.
• Management concluded internal control over financial reporting was not effective as of 12/31/25 due to IT general control, IPE, reconciliation, and segregation-of-duties weaknesses; no formal cybersecurity program yet.
• Auditor changed to CBIZ CPAs P.C. on October 6, 2025 following Smythe LLP’s resignation on September 25, 2025.
• Common shares outstanding were 55,300,085 at 12/31/25; trades on TSX (KLS) and OTC (KIQSF) after NYSE American delisting effective March 26, 2024.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a measured positive: a return to profitability and cost discipline offset by internal control weaknesses, flat revenue, and a pushed-out K2AV approval timeline.

Positives

• Return to profitability in 2025 with net income of $447,397 and positive Adjusted EBITDA of $347,723.
• Expenses reduced to $3,989,053 (from $5,527,559), reflecting successful cost controls.
• Working capital strengthened to $2,541,625; undrawn $1,000,000 credit facility adds liquidity flexibility.
• K2AV field trials substantially complete with no major issues reported; AAR approval expected in 2026, enabling full pressure car kit commercialization.
• Potential to increase revenue per pressure tank car from ~$1,500 to over $10,000 once the full kit is approved and offered.
• Domestic U.S. manufacturing and sourcing help insulate operations from international tariff volatility.
• No long-term interest-bearing debt; strong gross margin of 41% remains above typical industry suppliers.

Negatives

• Gross margin declined to 41% (from 44%) on sales mix and COGS treatment of inventory write-offs; revenue was essentially flat YoY.
• High customer concentration: four major OEMs/partners drive a substantial portion of revenue; no long-term purchase agreements.
• Material weaknesses in internal controls (ITGC, IPE, reconciliations, segregation of duties) and lack of formal cybersecurity program.
• Cash balance modest at $399,375; total assets declined to $5,469,476 (from $6,570,345).
• KXI project discontinued with prior impairments; ongoing severance/legal costs impacted 2025 first-half expenses.
• Auditor change during the year (Smythe LLP resigned; CBIZ appointed), which can raise process scrutiny.
• Tariff and trade policy uncertainty pressured later-2025 demand and supply chains; industry new-build tank car production slowed.

Risks

• Failure to obtain and maintain AAR approvals (e.g., K2AV angle valve) could limit revenue growth and market access.
• Intellectual property risks, including inability to secure adequate patents/trademarks or potential third-party infringement claims.
• R&D outcomes are uncertain; testing could deem products technologically/economically infeasible.
• Tariff and trade measures (and evolving policies) may increase input costs, disrupt supply chains, and impair margins and demand.
• Geopolitical conflicts and related sanctions can disrupt shipping routes, increase energy prices, and elevate market uncertainty.
• Limited earnings history with prior net losses; may require additional capital during working capital deficits.
• New markets may develop slower than anticipated; unforeseen competition could compress share and pricing.
• Order cancellations or rescheduling risk without long-term purchase commitments.
• Dependency on a small number of OEM customers; loss of a key account would materially impact results.
• Potential shortages of parts/raw materials and production capacity constraints during upswings.
• Exposure to raw material price volatility (e.g., steel, rubber) that may not be fully passed through.
• Reliance on key senior executives; loss could disrupt operations.
• Material weaknesses in internal control over financial reporting and absence of formal cybersecurity program as of 12/31/25.

Future Outlook

Management expects AAR approval of the K2AV angle valve in 2026, completing Kelso’s pressure car kit and enabling materially higher revenue per pressure tank car. Field trials for bottom outlet and angle valves remain in progress. Revenue opportunities exist in repair/retrofit and requalification markets (40,000–50,000 cars annually) while new-build demand is expected to dip in 2026 (7,875 units) before rebounding. Cost discipline will continue; no material capex planned. Strategic alternatives for KXI technology (sale/licensing/royalties) are being explored.

Management Comments

• Fiscal 2025 was a turn-around year as the team refocused on the core valve business and discontinued KXI operations.
• Valve sales were strong in Q1 2025 but slowed later as tariffs disrupted supply chains and raised raw material costs.
• K2AV’s field service trial completed most required loaded trips and miles, and approval is anticipated in 2026, with no major issues reported by customers.
• Completion of the pressure car package could increase per-car revenue from roughly $1,500 to over $10,000.
• The line of credit was increased to $1 million; cost controls were tightened, and non-essential travel curtailed.
• Operations are structured to withstand a weak tank car market; greater diversification will be needed to fund capex and growth.

Industry Context

StockSavvy.ai notes that North American railcar manufacturing and retrofit cycles remain cyclical, with steel tariffs and trade-policy shifts pressuring costs and demand. Industry forecasts cited indicate new tank car builds dipping in 2026 before recovering, while requalification work provides steadier volumes. Kelso’s domestic U.S. sourcing is a competitive advantage amid tariff volatility, and completing the AAR-approved pressure car kit could expand wallet share with OEMs and repair shops despite cyclical headwinds.

Comparison to Industry Standards

• Gross margin: Kelso’s 41% gross margin is notably higher than large diversified rail suppliers such as Wabtec (historically mid-20s gross margin) and railcar OEMs like Trinity Industries and The Greenbrier Companies (manufacturing margins typically lower due to integrated build economics).
• Scale and concentration: Unlike Trinity or Greenbrier, which are diversified manufacturers/leasers, Kelso is a niche component supplier with higher customer concentration and no long-term purchase commitments—raising volatility vs. larger peers.
• Regulatory cycle: Time-to-approval via AAR field trials is standard across the sector; slippage from initial targets (to 2026) is not uncommon relative to large-cap peers’ product qualification cycles, but impacts Kelso more due to size.
• Balance sheet: Kelso operates with no long-term debt and a modest cash balance, contrasting with larger peers that typically maintain broader liquidity pools and term debt structures; Kelso’s $1m revolving facility provides tactical flexibility.

Management Changes

Corporate Governance

Legal Proceedings

• No material legal or arbitration proceedings disclosed for 2025; prior G&J Technologies arbitration was resolved and paid in 2023.

Related Party Transactions

• Management compensation totaled $791,923 in 2025; directors’ fees $124,375.
• In 2024, $30,000 was paid to a consulting company owned by the spouse of the former CEO (agreement terminated in Q2 2024).
• Share-based expenses to directors and officers recognized (RSUs), with some RSU repurchases for cash.

Stakeholder Impact

• Shareholders: Return to profit and improved liquidity are positives; internal control weaknesses and delayed K2AV approval elevate risk.
• Employees: Headcount reduced to 22 (from 29) via attrition and reorganization; focus on cost controls.
• Customers: Continued domestic production and sourcing support reliability amid tariffs; expanded pressure car kit could deepen relationships.
• Suppliers: Stable demand tied to repair/retrofit and future product approvals; tariff volatility remains a consideration.
• Creditors/Lenders: Liquidity improved with undrawn $1m revolver; positive EBITDA and profit enhance credit profile.

Next Steps

• Finalize K2AV field service reporting and pursue AAR approval targeted in 2026.
• Advance AAR field trials for bottom outlet valves and continue pressure car kit commercialization planning.
• Sustain cost control measures and manage sales mix to stabilize gross margins.
• Evaluate strategic alternatives for KXI technology (sale, licensing, royalty agreements).
• Remediate internal control material weaknesses and implement formal cybersecurity risk management.
• Leverage domestic sourcing and the $1m credit facility to navigate tariff and supply-chain volatility.

Key Dates

Recommendation

The shift to profitability, cost reductions, and impending K2AV approval are constructive, but the flat revenue, internal control weaknesses, modest cash, and an approval timeline now extending into 2026 argue for patience. Maintain a hold pending clear AAR approval and control remediation progress.

Keywords

Kelso Technologies, rail tank car valves, AAR approval, K2AV angle valve, pressure car kit, bottom outlet valve, vacuum relief valve, hazmat containment, Bonham Texas manufacturing, tariffs, Adjusted EBITDA, IFRS, TSX KLS, OTC KIQSF, internal controls weakness, credit facility